home / stock / gnft / gnft quote
Last: | $ |
---|---|
Change Percent: | 1.52% |
Open: | $18.00 |
Close: | $18.00 |
High: | $18.10 |
Low: | $17.783 |
Volume: | 47,581 |
Last Trade Date Time: | 02/12/2020 04:40:52 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $18.00 | $18.00 | $18.10 | $17.783 | 47,581 | 02-12-2020 |
$ | $17.95 | $17.73 | $17.99 | $17.50 | 37,868 | 02-11-2020 |
$ | $16.80 | $17.10 | $17.375 | $16.80 | 42,595 | 02-10-2020 |
$ | $17.25 | $17.00 | $17.95 | $16.97 | 46,685 | 02-07-2020 |
$ | $17.34 | $17.93 | $18.13 | $17.33 | 160,372 | 02-06-2020 |
$ | $17.52 | $17.50 | $17.7499 | $17.35 | 45,409 | 02-05-2020 |
$ | $17.85 | $17.66 | $17.94 | $17.60 | 33,148 | 02-04-2020 |
$ | $17.37 | $17.52 | $17.8148 | $17.28 | 26,793 | 02-03-2020 |
$ | $17.43 | $17.01 | $17.4783 | $16.97 | 31,883 | 01-31-2020 |
$ | $17.50 | $17.69 | $17.8999 | $17.45 | 107,986 | 01-30-2020 |
$ | $17.92 | $18.09 | $18.09 | $17.85 | 39,100 | 01-29-2020 |
$ | $17.78 | $17.72 | $18.03 | $17.58 | 61,107 | 01-28-2020 |
$ | $18.05 | $18.09 | $18.55 | $17.91 | 84,204 | 01-27-2020 |
$ | $18.80 | $19.28 | $19.42 | $17.8601 | 135,225 | 01-24-2020 |
$ | $18.66 | $19.40 | $19.985 | $18.48 | 171,534 | 01-23-2020 |
$ | $20.22 | $20.18 | $20.41 | $19.80 | 44,641 | 01-22-2020 |
$ | $20.52 | $20.52 | $20.7612 | $20.33 | 21,342 | 01-21-2020 |
$ | $20.49 | $20.42 | $20.61 | $20.3379 | 32,874 | 01-20-2020 |
$ | $20.49 | $20.42 | $20.61 | $20.3379 | 32,874 | 01-17-2020 |
$ | $20.97 | $20.53 | $21.14 | $20.33 | 69,306 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
GENFIT S.A. Company Name:
GNFT Stock Symbol:
NYSE Market:
Lakeland Industries Inc. (LAKE) is expected to report $0.3 for Q4 2024 Sekisui House Ltd. ADR (SKHSY) is expected to report for Q4 2024 Hingham Institution for Savings (HIFS) is expected to report for Q1 2024 GENFIT S.A. (GNFT) is expected to report for Q4 2023 Jewett-Cameron Trad...
Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT for Development of Injectable Formulation of SRT-015 for Acute-on-Chronic Liver Disease (ACLF) PR Newswire Seal Rock eligible to receive payments up to €100 million, including regulatory, clinical,...